Clovis Oncology (CLVS) Stock Rating Upgraded by BidaskClub

James Marshall
April 16, 2018

Md Sass Investors Services Inc sold 217,460 shares as the company's stock declined 3.16% with the market. The Indexiq Advisors Llc holds 30,929 shares with $1.53M value, up from 19,027 last quarter. The company has market cap of $2.36 billion. The stock decreased 1.60% or $0.85 during the last trading session, reaching $52.25. Its down 75.25% from 81,200 shares previously. Delta Air Lines, Inc. Eurobank Ergasias S.A. (OTCMKTS:EGFEF) has 0.00% since April 14, 2017 and is. ValuEngine raised shares of Clovis Oncology from a "sell" rating to a "hold" rating in a report on Wednesday. Assetmark Inc acquired 23,538 shares as Novo (NVO)'s stock declined 9.08%. Greenwood Capital Associates LLC lifted its position in shares of Clovis Oncology by 21.6% in the 4th quarter.

The stock decreased 0.96% or $0.59 during the last trading session, reaching $60.85.Clovis Oncology, Inc. has volume of 147,590 shares. About 686,060 shares traded. Clovis Oncology, Inc. (NASDAQ:CLVS) has declined 21.43% since April 14, 2017 and is downtrending. CLVS underperformed the S&P 500 by 32.98%. SCG's profit would be $172.60 million giving it 7.42 P/E if the $1.21 EPS is correct. 894 shares valued at $50,511 were sold by Smith Joanne D on Monday, December 18. Focused Wealth Mngmt owns 1,015 shs. (NYSE:DAL) on Friday, February 2. (NYSE:DAL) was sold by Bastian Edward H. Another trade for 6,898 shares valued at $365,628 was made by Sear Steven M on Thursday, October 12.

Clovis Oncology Inc (CLVS) investors sentiment decreased to 1.05 in 2017 Q4. Its down 0.39, from 1.44 in 2017Q3. It dived, as 54 investors sold DAL shares while 267 reduced holdings. 40 funds opened positions while 74 raised stakes. Swiss Bankshares holds 79,050 shares. Barclays Plc holds 162,124 shs or 0.01% of its capital. Old Mutual Customised Solutions (Proprietary) accumulated 2,600 shares or 0.01% of the stock. Moreover, Pub Sector Pension Investment Board has 0.01% invested in Delta Air Lines, Inc. Venbio Select Advisor Llc owns 1.10 million shares or 4.86% of their United States portfolio. Alliancebernstein Limited Partnership reported 0.05% stake. Auxier Asset Management reported 13,670 shares stake. Martin Invest Management Limited Liability Corporation holds 118,878 shares. Friess Associates Limited Liability stated it has 1.73% of its portfolio in Delta Air Lines, Inc. Manufacturers Life Ins The invested in 33,486 shares or 0% of the stock. (NYSE:DAL). Moreover, Banced has 0.66% invested in Delta Air Lines, Inc.

Assetmark Inc increased Novo (NVO) stake by 374.63% reported in 2017Q4 SEC filing. 501,791 are held by National Bank Of Montreal Can. Therefore 67% are positive. Proctor & Gamble had 80 analyst reports since August 4, 2015 according to SRatingsIntel. Oppenheimer maintained the shares of CLVS in report on Monday, July 31 with "Hold" rating. On Friday, March 23 RBC Capital Markets maintained Clovis Oncology, Inc. The firm has "Outperform" rating given on Wednesday, July 6 by Cowen & Co. (NYSE:DAL) on Thursday, March 16 to "Outperform" rating. In Thursday, November 2 report Morgan Stanley maintained the stock with "Overweight" rating. On Tuesday, February 27 Stifel Nicolaus maintained the shares of CLVS in report with "Buy" rating. Clovis Oncology now has an average rating of Buy and an average price target of $87.60.

Assetmark Inc decreased Gramercy Ppty Tr Com New stake by 16,133 shares to 5,352 valued at $143,000 in 2017Q4. Sphera Funds Mgmt Limited has 158,000 shares.

Investors sentiment increased to 1.34 in 2017 Q4. Its up 0.24, from 1.1 in 2017Q3. The ratio turned negative due to Clovis Oncology, Inc. positioning: 35 sold and 69 reduced. Caprock Group Inc reported 53,414 shares. (NASDAQ:CLVS). Birchview LP invested in 0.2% or 5,000 shares. New York-based Goldman Sachs Grp Inc Inc has invested 0% in Clovis Oncology, Inc. (NASDAQ:CLVS). Trust Department Mb Bancorporation N A has invested 0% in Clovis Oncology, Inc. CLVS's SI was 7.44 million shares in April as released by FINRA. Glenmede Tru Na reported 0% in Clovis Oncology, Inc. (NASDAQ:CLVS) for 35,000 shares. Frontier Cap Ltd Co reported 43,276 shares. Clovis Oncology had 64 analyst reports since September 10, 2015 according to SRatingsIntel. Atwood And Palmer stated it has 25,436 shares. State Common Retirement Fund owns 48,300 shs for 0% of their capital. It also reduced its holding in Micron Technology Inc (NASDAQ:MU) by 663,841 shares in the quarter, leaving it with 775,667 shares, and cut its stake in Alcoa Corp.

Since January 1, 0001, it had 0 buys, and 6 insider sales for $1.37 million activity. Fmr Lc holds 2.23M shs. Clovis Oncology has a one year low of $45.42 and a one year high of $99.45. On Thursday, January 18 the stock of Clovis Oncology, Inc. (NASDAQ:CLVS) rating on Friday, February 26. The stock rating was maintained by SunTrust with "Buy" on Friday, April 6. The stock rating was maintained by Barclays Capital with "Overweight" on Tuesday, February 27. (NASDAQ:CLVS) on Wednesday, November 15 with "Buy" rating. On Thursday, November 16 the stock rating was upgraded by Guggenheim to "Neutral". The firm has "Neutral" rating given on Monday, April 4 by Piper Jaffray.

Other reports by Click Lancashire

Discuss This Article